Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Kroonilise hingamisteede haiguste küsimustik× | Sinonasal Outcome Test-22× | |
|---|---|---|
| Valdkond | Pulmonoloogia | Pulmonoloogia |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 1987 | 2009 |
| Looja≠ | Gordon H. Guyatt, McMaster University | Claire Hopkins, King's College London |
| Tüüp≠ | Self-report or interviewer-administered questionnaire | Self-report questionnaire |
| Algallikas≠ | Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax, 42(10), 773-778. DOI ↗ | Hopkins, C., Gillett, S., Slack, R., Lund, V. J., & Browne, J. P. (2009). Psychometric validity of the 22-item Sinonasal Outcome Test. Clinical Otolaryngology, 34(5), 447-454. DOI ↗ |
| Rööpnimetused | CRQ, Chronic Respiratory Q | SNOT-22, SNOT |
| Seotud | 5 | 5 |
| Kokkuvõte≠ | The CRQ is a 20-item, four-domain questionnaire developed by Guyatt and colleagues at McMaster University in 1987 to measure health-related quality of life specifically in patients with chronic respiratory disease, particularly chronic obstructive pulmonary disease and cystic fibrosis. Uniquely, the CRQ can be administered by interview or self-report, and its four domains (dyspnea, fatigue, emotional function, mastery) directly address the multidimensional burden of chronic respiratory disease. The CRQ has demonstrated exceptional responsiveness to pulmonary rehabilitation and other interventions, making it a preferred outcome measure in respiratory research and clinical practice. | The SNOT-22 is a 22-item disease-specific quality-of-life questionnaire designed to assess sino-nasal symptoms and their functional impact on patients with chronic rhinosinusitis, nasal polyposis, and allied conditions. Developed by Hopkins and colleagues at King's College London in 2009, it has become the most widely used instrument for measuring sino-nasal disease burden in clinical trials and rhinological practice. The SNOT-22 provides rapid, patient-centered assessment of both nasal-specific symptoms (congestion, drainage, sneezing) and general health impacts (sleep, headache, concentration). |
| ScholarGateAndmestik ↗ |
|
|